2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

Alunno A;Najm A;Machado PM;Bertheussen H;Burmester GR;Carubbi F;De Marco G;Giacomelli R;Hermine O;Isaacs JD;Koné-Paut I;Magro-Checa C;McInnes IB;Meroni PL;Quartuccio L;Ramanan AV;Ramos-Casals M;Rodríguez Carrio J;Schulze-Koops H;Stamm TA;Tas SW;Terrier B;McGonagle DG;Mariette X.

2022-01-01